Results 221 to 230 of about 1,681,802 (268)
Effectiveness and safety of fexinidazole for gambiense human African trypanosomiasis and exploration of adherence in outpatients: a phase 3b, prospective, open-label, non-randomised, cohort study.
Lancet Glob HealthKumeso VKB, Perdrieu C, Menétrey C, Kyhi MIW, Tete DN, Camara M, Tampwo J, Kavunga P, Camara ML, Kourouma A, Mindele WK, Masa FA, Mahenzi H, Makaya J, Malu TM, Mandula G, Nzambi DMM, Ntoya SL, Reymondier A, Kalonji WM, Scherrer B, Mordt OV. +21 moreeuropepmc +1 more sourceSpecificity of serological screening tests and reference laboratory tests to diagnose gambiense human African trypanosomiasis: a prospective clinical performance study. [PDF]
Infect Dis PovertyN'Djetchi MK, Camara O, Koffi M, Camara M, Kaba D, Kaboré J, Tall A, Rotureau B, Glover L, Traoré MB, Koné M, Coulibaly B, Adingra GP, Soumah A, Gassama M, Camara AD, Compaoré CFA, Camara A, Boiro S, Anton EP, Bessell P, Van Reet N, Bucheton B, Jamonneau V, Bart JM, Solano P, Biéler S, Lejon V. +27 moreeuropepmc +1 more sourceInterleukin 21 is a marker of Human African Trypanosomiasis Infection and a contributor to pathology in mice
Capewell P, Ilboudo H, Cooper A, Kaboré WJ, Noyes H, Neill KO, Camara M, Jamonneau V, MacLeod A, Bucheton B, TrypanoGEN+ research group of the H3Africa consortium. +10 moreeuropepmc +1 more sourceA Genome-Wide Association Study Reveals Novel Genetic Markers Associated with Human African Trypanosomiasis
Mulindwa J, Kimuda MP, Noyes H, Ilboudo H, Koffi M, Ahouty B, Nyangiri O, Cooper A, Clucas C, Nambala P, Musaya J, Ngoyi D́M, Karume K, Fataki O, Simo G, Ofon E, Enyaru J, Nerima B, Tait A, Marcello L, Chisi J, Kabore J, Kabore JW, Kamoto K, Simuunza M, Alibu VP, Jamonneau V, Camera M, Camara M, Bucheton B, Hertz-Fowler C, Macleod A, Matovu E, TrypanoGEN Research Group as members of The H3Africa Consortium. +33 moreeuropepmc +1 more source
